Drug Trial Radar · NCT02522338
Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma Clearance
Last checked: Nov 20, 2026Latest source record: Mar 10, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Feb 2011
Primary completion
Dec 2013
Study completion Dec 2013
Sponsor
- Lead sponsor
- Centre Hospitalier Universitaire de Saint EtienneAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 13, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Cystatin C, a protease inhibitor produced by most nucleated cells, is freely filtered by the kidneys, and its plasma assay reflects the GFR. Compare, in HIV patients, the predictive performance of 11 formula to estimate GFR based on assay plasma cystatin C with that of the MDRD formulas.
Conditions
- HIV
Interventions
iohexolDrug
10 ml de l'iohexol (300 mgI/ml)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient with a predictive performance range -30% to +30%Time frame: day 0
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CHU de SAINT-ETIENNE
Saint-Etienne, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.